- Home
- TMCI vs PRQR Comparison
TMCI vs PRQR Comparison
Compare TMCI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMCI
- PRQR
- Stock Information
- Founded
- TMCI 2014
- PRQR 2012
- Country
- TMCI United States
- PRQR Netherlands
- Employees
- TMCI N/A
- PRQR N/A
- Industry
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- TMCI Health Care
- PRQR Health Care
- Exchange
- TMCI Nasdaq
- PRQR Nasdaq
- Market Cap
- TMCI 329.0M
- PRQR 309.5M
- IPO Year
- TMCI 2021
- PRQR 2014
- Fundamental
- Price
- TMCI $7.83
- PRQR $3.62
- Analyst Decision
- TMCI Hold
- PRQR Strong Buy
- Analyst Count
- TMCI 6
- PRQR 4
- Target Price
- TMCI $7.40
- PRQR $7.13
- AVG Volume (30 Days)
- TMCI 780.3K
- PRQR 635.3K
- Earning Date
- TMCI 11-05-2024
- PRQR 11-07-2024
- Dividend Yield
- TMCI N/A
- PRQR N/A
- EPS Growth
- TMCI N/A
- PRQR N/A
- EPS
- TMCI N/A
- PRQR N/A
- Revenue
- TMCI $202,861,000.00
- PRQR $20,506,357.00
- Revenue This Year
- TMCI $13.15
- PRQR $298.83
- Revenue Next Year
- TMCI $8.36
- PRQR N/A
- P/E Ratio
- TMCI N/A
- PRQR N/A
- Revenue Growth
- TMCI 16.14
- PRQR 306.68
- 52 Week Low
- TMCI $3.92
- PRQR $1.18
- 52 Week High
- TMCI $15.98
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- TMCI 66.72
- PRQR 54.60
- Support Level
- TMCI $7.21
- PRQR $3.57
- Resistance Level
- TMCI $8.06
- PRQR $3.70
- Average True Range (ATR)
- TMCI 0.45
- PRQR 0.22
- MACD
- TMCI 0.04
- PRQR -0.08
- Stochastic Oscillator
- TMCI 82.14
- PRQR 18.06
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.